MR Linac

|A linear accelerator with built-in MRI that targets tumours while imaging them live. MR Linac is an advanced cancer treatment technology that seamlessly integrates a high-resolution Magnetic Resonance Imaging (MRI) scanner with a Linear Accelerator (Linac) into a single system. Often referred to as “smart radiotherapy,” this technology allows oncologists to visualize the tumor clearly and in real-time while delivering radiation.

What is MR Linac?

MR Linac is part of the advanced radiotherapy and radiosurgery technology our specialists use to treat international patients with precision. Modern systems like this often mean smaller interventions, greater accuracy and a smoother, faster recovery — always applied by experienced, multidisciplinary teams around each individual case.

The Era of Smart Radiotherapy: A Comprehensive Overview of MR Linac Technology in Oncology

The landscape of cancer treatment is experiencing a transformative shift with the advent of the MR Linac. By seamlessly integrating a high-resolution Magnetic Resonance Imaging (MRI) scanner with a Linear Accelerator (Linac) into a single, cohesive system, this breakthrough technology introduces the concept of “smart radiotherapy.” For the first time, oncologists can visualize tumors with diagnostic-level clarity in real-time while simultaneously delivering targeted radiation.

Unlike conventional modalities where a tumor’s location is mapped statically prior to treatment, the MR Linac allows medical teams to track anatomical changes and tumor movements during the actual procedure. This capability enables dynamic, instantaneous adjustments to radiation beams, ensuring unprecedented precision.

Mechanism of Action: How MR Linac Operates

The efficacy of the MR Linac system relies on the simultaneous execution of two core mechanisms:

• Continuous High-Definition MRI: Throughout the treatment fraction, the patient’s internal anatomy—including the tumor and adjacent organs—is monitored via a continuous, high-resolution MRI feed.

• Adaptive Target Tracking: Physiological functions such as respiration, swallowing, or peristalsis inevitably cause internal movement. The MR Linac system automatically adapts its radiation delivery to track the moving tumor, instantaneously pausing the beam if the target shifts outside the predetermined margins.

Primary Clinical Advantages

The integration of real-time imaging and radiation delivery provides several distinct advantages that elevate the standard of oncological care:

• Real-Time Precision: Tumors and critical surrounding structures are tracked with sub-millimeter accuracy during the exact moment of irradiation.

• Maximized Tissue Sparing: By tightly focusing the radiation beams on a dynamically tracked target, surrounding healthy tissues and critical organs (such as the heart, spinal cord, or kidneys) are spared from excess radiation toxicity.

• Daily Personalized Adaptation: Tumor morphology and position can alter significantly between sessions. The MR Linac facilitates daily online adaptation, allowing the clinical team to reshape the radiation plan based on the patient’s real-time anatomy on that specific day.

• Accelerated Treatment Timelines: Enhanced precision permits the safe delivery of higher radiation doses per fraction (hypofractionation). This can condense a traditional radiotherapy course spanning several weeks into just 1 to 5 highly focused sessions.

Key Clinical Indications

MR Linac is particularly advantageous for managing tumors located within highly mobile organs or situated dangerously close to critical anatomical structures. Primary clinical applications include:

• Prostate Cancer: Delivers targeted therapy to the prostate gland, which continuously shifts based on bladder and rectal filling.

• Pancreatic Cancer: Administers ablative doses safely while meticulously avoiding the highly radiosensitive stomach and duodenum.

• Liver Cancer: Accurately tracks hepatic tumors that migrate vertically with the respiratory cycle.

• Lung Cancer: Adapts instantaneously to respiratory motion, ensuring the beam remains locked on the pulmonary lesion.

• Breast Cancer: Significantly mitigates collateral risks for left-sided tumors located adjacent to the cardiac wall.

• Oligometastases: Provides highly targeted stereotactic body radiotherapy (SBRT) for localized metastatic spread in the brain, lymph nodes, or skeletal system.

Modality Comparison: MR Linac vs. Conventional Radiotherapy

To understand the clinical leap MR Linac represents, it is essential to compare it with standard radiotherapy protocols:

Clinical Feature	Conventional Radiotherapy	MR Linac Technology
Imaging Modality	Lower-resolution CT scans (Cone Beam CT)	High-resolution, real-time MRI
Tracking Capability	Static (Pre- and post-fraction verification)	Continuous, real-time intra-fraction tracking
Motion Management	Requires wider Planning Target Volume (PTV) margins	Beams adapt or pause instantly via gating
Toxicity Profile	Higher probability of collateral tissue damage	Minimized exposure to adjacent healthy tissue
Standard Duration	Typically 20 to 40 daily fractions	Typically 1 to 5 stereotactic fractions

The Patient Experience and Treatment Workflow

The clinical workflow for a patient undergoing MR Linac therapy is highly streamlined and patient-centric. It generally follows a three-step protocol:

1. Preparation and Imaging: The patient is positioned on the treatment couch, and a real-time, daily MRI scan is acquired.

2. On-Couch Adaptation: Utilizing the daily scan, the radiation oncologist and medical physics team optimize and generate a customized treatment plan tailored to that day’s specific internal anatomy.

3. Treatment Delivery: Radiation is administered while the patient remains inside the MRI bore. The system tracks the tumor continuously, delivering the prescribed dose painlessly. Following the session, patients can typically resume their normal daily activities immediately.

In summary, the MR Linac represents a monumental leap forward in radiation oncology. By removing the guesswork from tumor targeting, it offers patients a safer, faster, and highly personalized pathway to cancer treatment.

Why it matters

• Greater precision targeted to your specific condition.
• Minimally invasive options that can mean less discomfort.
• Faster recovery and a quicker return to daily life where appropriate.

What to expect

Before anything begins, our international patient team explains the process in your language and answers your questions. A specialist reviews your history and reports, confirms whether this technology is right for you, and prepares a clear, individual plan. Suitability always depends on your personal medical assessment.

Where it is used

This technology supports the work of our Radiation Oncology team(s). Contact us and we will confirm the most suitable hospital for your treatment.

Frequently asked questions

Is it safe?

These systems are used routinely in our JCI-accredited hospitals by trained specialists who follow strict safety standards. Your team will explain any specific considerations for your case.

Will my insurance cover it?

Coverage depends on your policy. Share your insurer with us and our team will check your options and explain any costs in advance.

How do I get started?

Send us your reports through a free consultation request. A specialist will review your case and tell you whether this technology fits your treatment plan.